142 related articles for article (PubMed ID: 37960805)
1. Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction.
Zhang C; Shen C
Medicine (Baltimore); 2023 Nov; 102(45):e35881. PubMed ID: 37960805
[TBL] [Abstract][Full Text] [Related]
2. Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning.
Feng H; Chen W; Zhang C
Medicine (Baltimore); 2023 Nov; 102(47):e35999. PubMed ID: 38013352
[TBL] [Abstract][Full Text] [Related]
3. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
4. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
5. Pyroptosis-related lncRNA prognostic signatures for cutaneous melanoma and tumor microenvironment status.
Deng H; Chen Y; An R; Wang J
Epigenomics; 2023 Jun; 15(12):657-675. PubMed ID: 37577979
[No Abstract] [Full Text] [Related]
6. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
8. Identification and targeting of cancer-associated fibroblast signature genes for prognosis and therapy in Cutaneous melanoma.
Zhang G; Ji P; Xia P; Song H; Guo Z; Hu X; Guo Y; Yuan X; Song Y; Shen R; Wang D
Comput Biol Med; 2023 Dec; 167():107597. PubMed ID: 37875042
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy.
Wan Q; Deng Y; Wei R; Ma K; Tang J; Deng YP
Aging (Albany NY); 2024 Mar; 16(5):4518-4540. PubMed ID: 38475660
[TBL] [Abstract][Full Text] [Related]
10. Identification of an endoplasmic reticulum stress-associated gene signature to predict the immune status and prognosis of cutaneous melanoma.
Chen R; Niu L; Wu L; He Y; Liu G; Hong K
Medicine (Baltimore); 2022 Sep; 101(36):e30280. PubMed ID: 36086718
[TBL] [Abstract][Full Text] [Related]
11. Identification of hub anoikis-associated genes and risk signature in cutaneous melanoma.
He YW; Fan QP; Hua AL; Liu Q
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5662-5676. PubMed ID: 37401304
[TBL] [Abstract][Full Text] [Related]
12. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
Song Z; Su M; Li X; Xie J; Han F; Yao J
BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
[TBL] [Abstract][Full Text] [Related]
13. A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma.
Li AA; Li F; Lan M; Zhang Y; Xie D; Yan MY
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3227-3241. PubMed ID: 35687183
[TBL] [Abstract][Full Text] [Related]
14. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
[TBL] [Abstract][Full Text] [Related]
15. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
16. A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs.
Zhang M; Zuo Y; Guo J; Yang L; Wang Y; Tan M; Guo X
Sci Rep; 2023 Sep; 13(1):16332. PubMed ID: 37770477
[TBL] [Abstract][Full Text] [Related]
17. Identification of oxeiptosis-associated lncRNAs and prognosis-related signature to predict the immune status in gastric cancer.
Wen L; Xu K; Huang M; Pan Q
Medicine (Baltimore); 2024 Feb; 103(7):e37189. PubMed ID: 38363905
[TBL] [Abstract][Full Text] [Related]
18. Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma.
Lin K; Zhou Y; Lin Y; Feng Y; Chen Y; Cai L
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189408
[TBL] [Abstract][Full Text] [Related]
19. The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma.
Wang G; Sun Y; Xu Q
Aging (Albany NY); 2023 Nov; 15(21):11918-11939. PubMed ID: 37921852
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma.
Zhu J; Deng J; Zhang L; Zhao J; Zhou F; Liu N; Cai R; Wu J; Shu B; Qi S
BMC Cancer; 2020 Sep; 20(1):927. PubMed ID: 32993558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]